.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,703,243

« Back to Dashboard

Details for Patent: 5,703,243

Title: Intermediates for pyrrolidylthiocarbapenem derivative
Abstract:A pyrrolidylthiocarbapenem derivative represented by Formula I is provided: ##STR1## wherein R.sup.1 is hydrogen or lower alkyl; R.sup.2, R.sup.3 and R.sup.4 are hydrogen, lower alkyl which can be substituted or an amino protecting group independently, or R.sup.2 and R.sup.3 together with a nitrogen atom to which R.sup.2 and R.sup.3 are bonded form a saturated or unsaturated cyclic group, or R.sup.2 and R.sup.4, or R.sup.3 and R.sup.4 together with two nitrogen atoms and one sulfur atom in the sufamide group form a saturated or unsaturated cyclic group; each cyclic group can further include at least one atom selected from the group consisting of oxygen, sulfur and nitrogen, and each cyclic group can be substituted; X.sup.1 is hydrogen or a hydroxy protecting group; X.sup.2 is hydrogen, a carboxy protecting group, an ammonio group, an alkali metal or an alkaline-earth metal; and Y.sup.2 is hydrogen or an amino protecting group.
Inventor(s): Nishitani; Yasuhiro (Izumi, JP), Irie; Tadashi (Suita, JP), Nishino; Yutaka (Neyagawa, JP)
Assignee: Shionogi Seiyaku Kabushiki Kaisha (Osaka, JP)
Filing Date:Dec 19, 1995
Application Number:08/574,863
Claims:1. A pyrrolidine derivative represented by Formula II: ##STR45## wherein R.sup.2, R.sup.3 and R.sup.4 are hydrogen, lower alkyl which can be substituted, or an amino protecting group independently, or R.sup.2 and R.sup.3 together with a nitrogen atom to which R.sup.2 and R.sup.3 are bonded form a saturated or unsaturated cyclic group, or R.sup.2 and R.sup.4, or R.sup.3 and R.sup.4 together with two nitrogen atoms and one sulfur atom in the sufamide group form a saturated or unsaturated cyclic group; each cyclic group can further include at least one atom selected from the group consisting of oxygen, sulfur and nitrogen, and each cyclic group can be substituted; Y.sup.1 is hydrogen or a mercapto protecting group; and Y.sup.2 is hydrogen or an amino protecting group.

2. A pyrrolidine derivative according to claim 1, wherein R.sup.4 is hydrogen.

3. A pyrrolidine derivative according to claim 1, wherein each of R.sup.2 and R.sup.3 is hydrogen, R.sup.4 is an amino protecting group, Y.sup.1 is hydrogen, and Y.sup.2 is an amino protecting group.

4. A pyrrolidine derivative according to claim 1, wherein each of R.sup.2 and R.sup.3 is hydrogen, R.sup.4 is t-butyloxycarbonyl, Y.sup.1 is hydrogen, and Y.sup.2 is t-butyloxycarbonyl.

5. A pyrrolidine derivative according to claim 1, wherein R.sup.2 and R.sup.3 together with a nitrogen atom to which R.sup.2 and R.sup.3 are bonded form a saturated or unsaturated cyclic group.

6. A pyrrolidine derivative according to claim 1, wherein R.sup.2 and R.sup.4 together with two nitrogen atoms and one sulfur atom in the sulfamide group form a saturated or unsaturated cyclic group.

7. A pyrrolidine derivative according to claim 1, wherein R.sup.3 and R.sup.4 together with two nitrogen atoms and one sulfur atom in the sulfamide group form a saturated or unsaturated cyclic group.

8. A pyrrolidine derivative according to claim 1, wherein R.sup.2, R.sup.3 and R.sup.4 are independently selected from hydrogen, hydroxy substituted lower alkyl, amino substituted lower alkyl, alkoxy substituted lower alkyl, acylamino substituted lower alkyl, lower alkylamino substituted lower alkyl, carbamoyl substituted lower alkyl, lower alkylcarbamoyl substituted lower alkyl, carbamoyloxy substituted lower alkyl, lower alkylcarbamoyloxy substituted lower alkyl, and cyano substituted lower alkyl.

9. A pyrrolidine derivative according to claim 1, wherein at least one of R.sup.2, R.sup.3 and R.sup.4 is a lower alkyl which can be substituted, and the lower alkyl comprises 1 to 6 carbon atoms.

10. A pyrrolidine derivative represented by Formula II: ##STR46## wherein R.sup.2, R.sup.3 and R.sup.4 are hydrogen, lower alkyl which can be substituted, or an amino protecting group independently; Y.sup.1 is hydrogen or a mercapto protecting group; and Y.sup.2 is hydrogen or an amino protecting group.

11. A pyrrolidine derivative according to claim 10, wherein R.sup.2, R.sup.3 and R.sup.4 are independently selected from hydrogen, hydroxy substituted lower alkyl, amino substituted lower alkyl, alkoxy substituted lower alkyl, acylamino substituted lower alkyl, lower alkylamino substituted lower alkyl, carbamoyl substituted lower alkyl, lower alkylcarbamoyl substituted lower alkyl, carbamoyloxy substituted lower alkyl, lower alkylcarbamoyloxy substituted lower alkyl, and cyano substituted lower alkyl.

12. A pyrrolidine derivative according to claim 10, wherein at least one of R.sup.2, R.sup.3 and R.sup.4 is a lower alkyl which can be substituted, and the lower alkyl comprises 1 to 6 carbon atoms.

13. A pyrrolidine derivative according to claim 10, wherein R.sup.4 is hydrogen.

14. A pyrrolidine derivative represented by Formula II: ##STR47## wherein R.sup.2, R.sup.3 and R.sup.4 are independently hydrogen, or an amino protecting group, or an R.sup.2 and R.sup.3 together with a nitrogen atom to which R.sup.2 and R.sup.3 are bonded form a saturated or unsaturated cyclic group, or R.sup.2 and R.sup.4, or R.sup.3 and R.sup.4 together with two nitrogen atoms and one sulfur atom in the sulfamide group form a saturated or unsaturated cyclic group; each cyclic group can further include at least one atom selected from the group consisting of oxygen, sulfur and nitrogen, and each cyclic group can be substituted; Y.sup.1 is hydrogen or a mercapto protecting group; and Y.sup.2 is hydrogen or an amino protecting group.

15. A pyrrolidine derivative according to claim 14, wherein R.sup.2 and R.sup.3 together with a nitrogen atom to which R.sup.2 and R.sup.3 are bonded form a saturated or unsaturated cyclic group.

16. A pyrrolidine derivative according to claim 14, wherein R.sup.2 and R.sup.4 together with two nitrogen atoms and one sulfur atom in the sulfamide group form a saturated or unsaturated cyclic group.

17. A pyrrolidine derivative according to claim 14, wherein at least one R.sup.2 and R.sup.3, R.sup.2 and R.sup.4 and R.sup.3 and R.sup.4 form a saturated or unsaturated cyclic group, and the saturated or unsaturated cyclic group is selected from 1,1-dioxothiadiazinyl; 1,1-dioxodihydrothiadiazinyl; 1,1,3-trioxodihydrothiadiazinyl; 1,1-dioxothiadiazolizinyl; 1,1-dioxothiadiazolinyl; 1,1,3-trioxothiadiazolinyl.

18. A pyrrolidine derivative according to claim 14, wherein R.sup.4 is hydrogen.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc